tiprankstipranks
Aslan Pharmaceuticals Ltd ADR (ASLN)
NASDAQ:ASLN

Aslan Pharmaceuticals (ASLN) Balance Sheet

407 Followers

Aslan Pharmaceuticals Balance Sheet

Aslan Pharmaceuticals's total assets for Q were $24.63M, a decrease of -59.75% from the previous quarter. ASLN total liabilities were $37.91M for the fiscal quarter, a -28.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 24.63M$ 61.19M$ 4.35M$ 16.08M$ 23.28M
Total Liabilities
$ 37.91M$ 52.82M$ 100.23M$ 16.08M$ 23.42M
Total Equity Gross Minority
$ -13.29M$ 8.37M$ -5.72M$ -71.98M$ -61.97M
Total Capitalization
$ 11.51M$ 38.02M$ 25.14M$ -57.10M$ -45.98M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Aslan Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis